CorVel Corporation

NASDAQ:CRVL

Insurance - Brokers

Financial Services
$88.87 -0.12%

-$0.07 today

Market cap
$4.47B
Beta
0.98
P/E (TTM)
26.9
EPS (TTM)
$2.16
52W Low $44.83High $105.51

Volume 0.26M

Average 0.22M

CRVL Net Income

Bottom-line profit after all expenses, interest, and taxes.

CorVel CorporationNASDAQ: CRVL

Net Income · Q2 FY2027 · quarter ended Sep 2026

Net income growth accelerates

Q2 FY2027 net income of $34.09M rose 22.1% year over year, ahead of the +15.4% change in trailing-twelve-month net income. Sequentially, it rose 5.8% from the prior quarter. Over 3 fiscal years it compounded at +18.5% a year.

Context

  • Net income amounted to 11.5% of revenue in FY2026, up 0.9 pp from a year earlier.
  • Net income increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +22.1% holds above the trailing-twelve-month pace of +15.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$34.09M+5.8% QoQ
Last fiscal yearMar 2026
$110.34M+16.0% YoY
LTMSep 2026
$121.52M+15.4% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+22.1%——
1 year+16.0%——
3-year CAGR+18.5%——
5-year CAGR——
10-year CAGR——

Net Income history

USD · from the income statement

Latest · FY2026
110.34M USD
Year-over-year change
+16.0%
4-year CAGR
+13.5%

Net Income vs competitors

How CRVL compares with its peers on the latest reported figures

  • CRVL's LTM Sep 2026 net income of $121.52M is the 2nd highest of the 4 companies compared; the peer median is -$286.52M.
  • Its year-over-year change of +15.4% is the 3rd highest of 4, against a peer median of +62.2%.
  • Net income amounts to 12.0% of revenue for CRVL, versus a peer median of 26.3%.
CRVL Competitors Peer median
Net Income for CRVL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HQYHealthEquity, Inc.LTM Jul 2026$236.49M +62.2%—17.4%
CRVLCorVel CorporationLTM Sep 2026$121.52M +15.4%+18.5%12.0%
CTEVClaritev CorporationLTM Mar 2026-$286.52M +75.7%—29.3%
EVHEvolent Health, Inc.LTM Mar 2026-$496.52M -355.7%—26.3%
Peer median (excluding CRVL) -$286.52M+62.2%—26.3%

Competitors are the stored peer set for CRVL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue646.23M718.56M795.31M895.59M958.53M
Cost of Revenue494.12M560.3M623.62M685.86M725.66M
Gross Profit152.11M158.26M171.69M209.73M232.86M
Gross Margin23.5%22.0%21.6%23.4%24.3%
Research & Development00000
Selling, General & Admin67.6M73.71M76.59M88.9M89.73B
Operating Expenses67.6M73.71M76.59M88.9M89.73M
Depreciation & Amortization23.92M25.12M26.25M29.54M31.76M
EBITDA108.43M109.68M121.35M150.36M174.9M
EBITDA Margin16.8%15.3%15.3%16.8%18.2%
Operating Income84.51M84.55M95.1M120.82M143.13M
Operating Margin13.1%11.8%12.0%13.5%14.9%
Interest Income00000
Interest Expense00000
Other Income / Expenses00000
Income Before Tax84.51M84.55M95.1M120.82M143.13M
Pre-Tax Margin13.1%11.8%12.0%13.5%14.9%
Income Tax Expense18.1M18.19M18.85M25.66M32.79M
Net Income66.41M66.37M76.25M95.17M110.34M
Net Margin10.3%9.2%9.6%10.6%11.5%
EPS (Basic)1.251.281.481.852.15
EPS (Diluted)1.221.261.471.832.14
Weighted Avg Shares53.26M51.98M51.37M51.39M51.28M
Weighted Avg Shares (Diluted)54.38M52.78M52.04M52.04M51.63M

CorVel Corporation

NASDAQ:CRVL

Intrinsic Alpha fair value

Locked

Current Price

$88.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.